Focusing on functional vision with monofocal lenses

News
Article
Ophthalmology Times EuropeOphthalmology Times Europe March 2024
Volume 20
Issue 2
Pages: 6 - 10

Quantitative and qualitative improvement in IOL design

Cataract surgery is the most common surgical procedure in the EU, with 4.32 million surgeries performed across the EU member countries in 2021 alone.1 Though the National Institute for Health and Care Excellence guidelines recommend using a reduction in quality of life as the threshold for cataract surgery,2 visual acuity-based quantitative thresholds are still widely used.3 However, visual acuity has not been found to be entirely associated with quality of life after cataract surgery, suggesting that improvement in visual acuity alone is not sufficient for true patient satisfaction.4,5 In recent years, several novel IOLs have been introduced whose innovative designs reflect a trend towards prioritising functional vision. Significant advances in this space are anticipated in the coming years.

Functional vision

As opposed to visual acuity testing, which is done in ideal settings like an ophthalmologist’s practice, functional vision can be defined as the amount of vision required to independently perform activities of daily living.6 Studies have found contrast sensitivity, glare and stereopsis to be better predictors of patient satisfaction after cataract surgery, as these qualitative factors affect one’s visual ability in everyday life, such as with driving at nighttime, seeing through fog or recognising faces.4,7,8

Another aspect of functional vision is visual ability at a range of distances needed to perform activities of daily living. Many tasks are done at intermediate or near distances, especially with use of digital devices.9,10 Intermediate and near vision are also important for leisure and physical activities, which account for most daily activities with increasing age.11

Options for IOL implantation after cataract surgery included monofocal IOLs, which provided clear distance vision but poor intermediate and even worse near vision, or multifocal IOLs, which provided different levels of spectacle independence at the cost of visual quality, and insufficient intermediate vision depending on the power addition.12,13 Hence, both monofocal and multifocal lenses lacked efficacy in terms of functional vision. There was a need for an IOL that provided good intermediate vision and spectacle independence with fewer or no compromises in visual quality; this led to the development of the increased range of focus (IROF) IOLs.

Increased range of focus IOLs

IROF IOLs extend the depth of focus by creating an elongated focal point, providing intermediate vision while preserving distance visual acuity.14 This allows patients to be spectacle independent over a wider range of vision than with monofocal IOLs.15 Since light is focused on a single, albeit elongated, focal point instead of being split and projected simultaneously onto the retina (as in multifocal IOLs), photic phenomena like glares and halos are reduced.15

IROF IOLs achieve extended depth of focus (EDOF) by using different mechanisms of action; e.g. narrowing the aperture (pinhole effect) or by utilising spherical aberrations.14 The IC-8 Apthera (AcuFocus, Inc.) is a small-aperture IOL where an opaque, annular, filtering element of 3.23-mm outer diameter and 1.36-mm inner diameter filters out peripheral, defocused light rays to improve range and quality of vision.14 It has been proven to provide good distance, intermediate, and near vision, with visual quality comparable to a monofocal IOL.16 The Mini WELL IOL (SIFI Medtech) is an aberration-based IOL where the optic is divided into annular zones, with the outermost ring being monofocal, while the middle ring has negative spherical aberration for near vision, and the innermost ring has positive spherical aberration that provides intermediate vision.14 It performs well over all ranges of vision, with excellent intermediate vision and no significant dysphotopsias.17

Other IROF IOLs employ different mechanisms, e.g. diffraction, similar to multifocal IOLs, to reach an EDOF-like effect.14 The most studied example is the TECNIS Symfony IOL (Johnson & Johnson Vision): a bifocal diffractive IOL with low add power for intermediate vision, anterior aspheric surface and posterior achromatic diffractive surface. The echelette design on the posterior surface extends the depth of focus and reduces corneal chromatic aberration (Figure 1).14 While it provides an increased range of focus with high spectacle independence,15 its diffractive design can cause some photic phenomena.18

Non-diffractive IROF IOLs function by modifying the geometry of the IOL optic.14 The lack of diffractive components eliminates photic phenomena, resulting in contrast sensitivity and visual quality similar to that provided by monofocal IOLs while providing more spectacle independence and preserved intermediate vision as compared to monofocal IOLs.19 These are termed enhanced monofocal IOLs.

Enhanced monofocal IOLs

Enhanced monofocal IOLs improve upon the drawbacks of monofocal and multifocal IOLs to provide true functional vision over a wide range of distances. These lenses provide distance and intermediate vision comparable to other IROF IOLs,20 with more correction of functional near vision compared to monofocal IOLs and no compromise in visual quality.19

The first enhanced monofocal IOL was the TECNIS Eyhance IOL (Johnson & Johnson Vision).21 It is characterised by a smooth and continuous increase in IOL power from the periphery to the centre (Figure 2) and a higher-order aspheric design compensating for corneal aberrations, improving intermediate vision while preserving distance vision and achieving quality of vision comparable to monofocal IOLs, as per data from several studies.19,21

The aberration-negative AcrySof IQ Vivity IOL (Alcon) employs a proprietary X-wave wavefront shaping technology (Figure 3) that utilises a plateau on its aspheric anterior surface approximately 1 μm in height along with a small curvature change to stretch the wavefront of oncoming light and create a continuous extended range of focus.14 It has demonstrated good distance and intermediate vision with better spectacle independence than monofocal IOLs while maintaining comparable retinal image quality and high satisfaction rates.22,23 In a recent presentation at the 2023 European Society of Cataract and Refractive Surgeons (ESCRS) Congress, Dr Damien Gatinel noted that diffractive ring-like structures on microscopic examination of the IOL optic in vivo, with patients looking slightly off-centre, correspond with the findings of an optical bench analysis which showed that the central ~1 µm element had a sharp, diffractive edge, resulting in a risk of dysphotopsias with this IOL.24 Further, aberration-negative optics are more sensitive to decentration and tilt, and compromise in visual performance due to IOL decentration has been reported, perhaps due to the small, central optical zone of the lens.25

One of the latest entrants to the group of enhanced monofocal IOLs is the RayOne EMV IOL (Rayner), which has received much attention since its launch in 2020 and a subsequent presentation of data at
the 2023 ESCRS Congress.26 It is the only enhanced monofocal IOL utilising controlled positive spherical aberration in the IOL optic centre to increase the range of clear vision and provide high-quality distance and intermediate vision.27 Its blended edge gradually reduces longitudinal spherical aberration towards the periphery to maintain contrast sensitivity under varying ambient light levels (Figure 4). Early and more recent results
have been promising, demonstrating good distance and intermediate vision with functional useful near vision, no dysphotopsias or decreased contrast, and high patient satisfaction with quality of vision comparable to monofocal IOLs.27-30 The toric version is also available on the same RayOne
IOL platform, which has demonstrated good rotational stability and centration.31–33

The RayOne EMV IOL is the first IOL specifically optimised for mini- or modest-monovision (anisometropia between 0.50 D and 1.50 D).27 It elongates optical performance in the hyperopic direction, imparting some distance vision to the non-dominant eye (typically responsible for near vision in a monovision arrangement), creating a smoother transition between the dominant and non-dominant eye, with the large overlap between both eyes providing a wide range of binocular vision (Figure 5).34

A 1.0-D offset can result in 2.5-D increased depth of field (Figure 5). The IOL directs light rays myopically, providing intermediate vision, as well as hyperopically, giving a wider landing zone to the IOL that makes it forgiving of missed target refraction. Since its launch, RayOne EMV has shown high rates of spectacle independence for distance and intermediate vision, with patients achieving functional near vision and requiring minimal reading addition for reading fine print.27,32 In my own experience, a study of 100 eyes implanted with the RayOne EMV in my practice found postoperative binocular uncorrected visual acuity to be 0.1 logMAR or less for distance in 100% of eyes, 0.4 logMAR or less for intermediate (N8) in 100% of eyes, and 0.4 logMAR or less for near (N8) in 92% of eyes.35

Conclusion

Recent innovations in IOL design now enable surgeons to provide quantitative as well as qualitative visual improvement to patients. In particular, the enhanced monofocal IOLs are a promising group, with priority given to achieving functional vision over a broad range of distances with no loss in the quality of retinal images. With further research and optimisation, these IOLs can become the preferred choice for both surgeons and patients in the coming years.

References

1. Cataract surgeries down 4% in 2021. Eurostat. Accessed December 20, 2023. https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20230912-1
2. Overview, Cataracts in adults: management. NICE. Accessed December 20, 2023. https://www.nice.org.uk/guidance/ng77
3. Coronini-Cronberg S, Lee H, Darzi A, Smith P. Evaluation of clinical threshold policies for cataract surgery among English commissioners. J Health Serv Res Policy. 2012;17(4):241-247. doi:10.1258/jhsrp.2012.012023
4. Datta S, Foss AJE, Grainge MJ, Gregson RM, Zaman A, Masud T, Osborn F, Harwood RH. The Importance of Acuity, Stereopsis, and Contrast Sensitivity for Health-Related Quality of Life in Elderly Women with Cataracts. Investigative Opthalmology & Visual Science. 2008;49(1):1. doi:10.1167/iovs.06-1073
5. Acosta-Rojas ER, Comas M, Sala M, Castells X. Association Between Visual Impairment and Patient-Reported Visual Disability at Different Stages of Cataract Surgery. Ophthalmic Epidemiol. 2006;13(5):299-307. doi:10.1080/09286580600694464
6. Ribeiro F, Cochener B, Kohnen T, Mencucci R, Katz G, Lundstrom M, Casanovas AS, Hewlett D. Definition and clinical relevance of the concept of functional vision in cataract surgery ESCRS Position Statement on Intermediate Vision. J Cataract Refract Surg. 2020;46(1):S1-S3. doi:10.1097/j.jcrs.0000000000000096
7. Aslam TM, Haider D, Murray IJ. Principles of disability glare measurement: an ophthalmological perspective. Acta Ophthalmol Scand. 2007;85(4):354-360. doi:10.1111/j.1600-0420.2006.00860.x
8. McCulloch DL, Loffler G, Colquhoun K, Bruce N, Dutton GN, Bach M. The effects of visual degradation on face discrimination. Ophthalmic and Physiological Optics. 2011;31(3):240-248. doi:10.1111/j.1475-1313.2011.00828.x
9. Ribeiro F, Ferreira TB, Silva D, Matos AC, Gaspar S, Piñero DP. Analysis of Daily Visual Habits in a Presbyopic Population. J Ophthalmol. 2023;2023:6440954. doi:10.1155/2023/6440954
10. Adults’ Media Use and Attitudes Report. Accessed December 20, 2023. https://www.ofcom.org.uk/__data/assets/pdf_file/0011/113222/Adults-Media-Use-and-Attitudes-Report-2018.pdf
11. Time Use in the UK - Office for National Statistics. Accessed December 20, 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/personalandhouseholdfinances/incomeandwealth/bulletins/timeuseintheuk/march2023
12. Khandelwal SS, Jun JJ, Mak S, Booth MS, Shekelle PG. Effectiveness of multifocal and monofocal intraocular lenses for cataract surgery and lens replacement: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):863-875. doi:10.1007/s00417-018-04218-6
13. Böhm M, Petermann K, Hemkeppler E, Kohnen T. Defocus curves of 4 presbyopia-correcting IOL designs: Diffractive panfocal, diffractive trifocal, segmental refractive, and extended-depth-of-focus. J Cataract Refract Surg. 2019;45(11):1625-1636. doi:10.1016/j.jcrs.2019.07.014
14. Megiddo-Barnir E, Alió JL. Latest Development in Extended Depth-of-Focus Intraocular Lenses: An Update. Asia-Pacific Journal of Ophthalmology. 2023;12(1):58-79. doi:10.1097/APO.0000000000000590
15. Pedrotti E, Carones F, Aiello F, Mastropasqua R, Bruni E, Bonacci E, Talli P, Nucci C, Mariotti C, Marchini G. Comparative analysis of visual outcomes with 4 intraocular lenses: Monofocal, multifocal, and extended range of vision. J Cataract Refract Surg. 2018;44(2):156-167. doi:10.1016/j.jcrs.2017.11.011
16. Hooshmand J, Allen P, Huynh T, Chan C, Singh R, Moshegov C, Agarwal S, Thornell E, Vote BJ. Small aperture IC-8 intraocular lens in cataract patients: achieving extended depth of focus through small aperture optics. Eye (Lond). 2019;33(7):1096-1103. doi:10.1038/s41433-019-0363-9
17. Savini G, Schiano-Lomoriello D, Balducci N, Barboni P. Visual Performance of a New Extended Depth-of-Focus Intraocular Lens Compared to a Distance-Dominant Diffractive Multifocal Intraocular Lens. J Refract Surg. 2018;34(4):228-235. doi:10.3928/1081597X-20180125-01
18. Escandón-García S, Ribeiro FJ, McAlinden C, Queirós A, González-Méijome JM. Through-Focus Vision Performance and Light Disturbances of 3 New Intraocular Lenses for Presbyopia Correction. J Ophthalmol. 2018;2018:6165493. doi:10.1155/2018/6165493
19. Wan KH, Au ACK, Kua WN, Ng ALK, Cheng GPM, Lam NM, Chow VWS. Enhanced Monofocal Versus Conventional Monofocal Intraocular Lens in Cataract Surgery: A Meta-analysis. J Refract Surg. 2022;38(8):538-546. doi:10.3928/1081597X-20220707-01
20. Jeon YJ, Yoon Y, Kim TI, Koh K. Comparison Between an Intraocular Lens With Extended Depth of Focus (Tecnis Symfony ZXR00) and a New Monofocal Intraocular Lens With Enhanced Intermediate Vision (Tecnis Eyhance ICB00). Asia Pac J Ophthalmol (Phila). 2021;10(6):542-547. doi:10.1097/APO.0000000000000439
21. Auffarth GU, Gerl M, Tsai L, Janakiraman DP, Jackson B, Alarcon A, Dick HB. Clinical evaluation of a new monofocal IOL with enhanced intermediate function in patients with cataract. J Cataract Refract Surg. 2021;47(2):184-191. doi:10.1097/j.jcrs.0000000000000399
22. Al-Amri SAJ, Alió JL, Milán-Castillo R, D’Oria F, Martinez-Abad A, Yebana P, Subirana N, Al-Harbi Z, Plaza-Puche AB, Alió Del Barrio JL. Clinical Retinal Image Quality of a Non-diffractive Wavefront-Shaping Extended Depth of Focus (Vivity) Intraocular Lens. J Refract Surg. 2023;39(2):103-110. doi:10.3928/1081597X-20221130-04
23. Hovanesian JA, Jones M, Allen Q. The Vivity Extended Range of Vision IOL vs the PanOptix Trifocal, ReStor 2.5 Active Focus and ReStor 3.0 Multifocal Lenses: A Comparison of Patient Satisfaction, Visual Disturbances, and Spectacle Independence. Clin Ophthalmol. 2022;16:145-152. doi:10.2147/OPTH.S347382
24. Gatinel D. Non-diffractive advanced optics, reality or myth? Presented at: ESCRS 2023 Congress; September 2023; Vienna, Austria.
25. Nowrouzi A, Alió del Barrio JL, Alió JL. Impact of Intraocular Lens Decentration on the Near Vision Performance of a Wavefront-Correcting Extended Depth of Focus IOL. Journal of Refractive Surgery Case Reports. 2022;2(2). doi:10.3928/jrscr-20220413-01
26. Otero C. ESCRS 2023 Scientific-Voice.Com Report.
27. RayOne EMV: First Clinical Results. Published 2020. Accessed December 20, 2023. https://rayner.com/wp-content/uploads/2021/11/RayOne-EMV-First-Clinical-Results.pdf
28. Findl O. Results from a comparative prospective study with RayOne EMV. Presented at: ESCRS 2023 Congress; September 2023; Vienna, Austria.
29. Barsam A. Comparing RayOne EMV and AcrySof IQ Vivity in a large cohort. Presented at: ESCRS 2023 Congress; September 2023; Vienna, Austria.
30. Madhivanan N, Nivean PD, Madanagopalan VG, Priya S, Madhivanan N, Arthi M. Clinical results after binocular implantation of a unique nondiffractive enhanced monofocal intraocular lens designed for enhanced monovision to increase the depth of focus. Indian J Ophthalmol. 2024;72(1):63-65. doi:10.4103/IJO.IJO_447_23
31. Bhogal-Bhamra GK, Sheppard AL, Kolli S, Wolffsohn JS. Rotational Stability and Centration of a New Toric Lens Design Platform Using Objective Image Analysis Over 6 Months. J Refract Surg. 2019;35(1):48-53. doi:10.3928/1081597X-20181204-01
32. Rayner. RayOne EMV Toric First-in-Eye Multicentre Real World Clinical Results. Accessed December 29, 2023. https://rayner.com/peer2peer/wp-content/uploads/sites/8/2023/06/RayOne-EMV-Toric-FIE-White-Paper.pdf
33. Rayner. Better Vision Without Compromise. Accessed December 29, 2023. https://theophthalmologist.com/subspecialties/better-vision-without-compromise
34. Rayner, data on file.
35. Mantry S. How spherical aberration is shaping the future of refractive surgery. In: 1st Zagreb Refractive Surgery Meeting 2023.

Sanjay Mantry, MD, FRCS, FRCOphth | e: sanjay@visionscotland.com

Mantry is a consultant ophthalmologist with interest in cornea, cataract and refractive surgery. He is the founder and managing director at Vision Scotland.

Financial disclosure: Mr Mantry is a consultant of Rayner.

Miss Catriona Kennedy, MCOptom

Kennedy is a refractive and independent prescribing optometrist who has worked for Vision Scotland since 2019. She provides pre-surgery assessments and post-operative care.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.